Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: Am J Hematol. 2017 Nov 27;93(2):277–285. doi: 10.1002/ajh.24972

TABLE 3.

Adverse events on study, regardless of causality

Toxicities Grade 1–2 N (%) Grade 3–4 N (%)
Constipation 8 (23)
Nausea/Vomiting 8 (23)
Diarrhea 3 (9)
Myalgias/Abdominal Pain 3 (9)
Chest pain 2 (6) 1 (3)
Anorexia 2 (6)
Dizziness 2 (6)
Fatigue 1 (3) 2 (6)
Bruising 2 (6)
Insomnia 1 (3)
Edema - limbs 1 (3) 1 (3)
Periorbital edema 1 (3) 1 (3)
Shingles 1 (3)
Actinic Keratosis 2 (6)
Urinary tract infections 2 (6) 3 (9)
Pneumonia 2 (6) 3 (9)
Skin/soft tissue infections 2 (6) 3 (9)
Constrictive pericarditis 1 (3)
Heart failure 1 (3) 3 (9)
Headache 1 (3)
Hyperuricemia 1 (3)
Transaminitis 7 (20)
Hyperbilirubinemia 2 (6)
Thrombocytopenia 7 (20) 19 (54)
Anemia 6 (17) 18 (51)
Neutropenia 1 (3) 10 (29)